Cost-minimisation analysis of subcutaneous methotrexate versus biologic therapy for the treatment of patients with rheumatoid arthritis who have had an insufficient response or intolerance to oral methotrexate

Author: Fitzpatrick Ray   Scott David   Keary Ian  

Publisher: Springer Publishing Company

ISSN: 0770-3198

Source: Clinical Rheumatology, Vol.32, Iss.11, 2013-11, pp. : 1605-1612

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content